Roche pauses shipments of Elevidys gene therapy outside US
(Reuters) -Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside the U.S., echoing a similar decision by U.S. partner Sarepta Therapeutics. The Swiss drugmaker said the pause, effective Tuesday, applies to new orders of Elevidys in countries outside the U.S. that reference the Food …
Roche pauses shipments of Elevidys gene therapy outside US Read More »









